Société Eledon Pharmaceuticals, Inc.
Actions
ELDN
US28617K1016
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,06 USD | -3,29 % | +9,57 % | +14,44 % |
Métier
Nombre d'employés: 17
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 51 | 01/05/20 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 15/03/21 |
Steven N. Perrin
PSD | President | 59 | 14/09/20 |
Eliezer Katz
CTO | Chief Tech/Sci/R&D Officer | - | 23/10/23 |
Amanda Hayden
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
John Herberger
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/22 |
Bryan E. Smith
CMP | Compliance Officer | 45 | 19/04/21 |
David Hovland
LAW | General Counsel | - | 19/04/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 01/05/17 |
Walter C. Ogier
BRD | Director/Board Member | 67 | 14/09/20 |
John S. McBride
BRD | Director/Board Member | 72 | 01/05/17 |
Steven N. Perrin
PSD | President | 59 | 14/09/20 |
Chief Executive Officer | 51 | 01/05/20 | |
James Robinson
BRD | Director/Board Member | 54 | 01/10/23 |
June Lee
BRD | Director/Board Member | 58 | 09/12/20 |
Jan L. Hillson
BRD | Director/Board Member | 71 | 02/07/21 |
Allan Kirk
BRD | Director/Board Member | - | 02/10/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 110 086 | 0 | 0 | 94,44 % |
Action B | 1 | 24 198 130 | 22 851 868 ( 94,44 %) | 0 | |
Action C | 0 | 4 422 | 0 | 0 |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+14,44 % | 49,85 M | |
+2,73 % | 108 Md | |
+9,59 % | 103 Md | |
+6,58 % | 23,48 Md | |
-12,59 % | 21,93 Md | |
-3,29 % | 19,68 Md | |
-35,36 % | 18,37 Md | |
-13,29 % | 16,33 Md | |
+4,68 % | 13,72 Md | |
+34,25 % | 12,15 Md |
- Bourse
- Actions
- Action Eledon Pharmaceuticals, Inc. - Nasdaq
- Société Eledon Pharmaceuticals, Inc.